Sanofi breaks ground on car­bon-neu­tral, mul­ti-vac­cine site in Sin­ga­pore

This time last year, Sanofi an­nounced it would spend $476 mil­lion on a new vac­cine man­u­fac­tur­ing site in Sin­ga­pore, in a move that it said would cre­ate 200 new jobs and pro­vide for flex­i­bil­i­ty in man­u­fac­tur­ing mul­ti­ple vac­cines at once. The French phar­ma gi­ant broke ground on the site Wednes­day, and added an­oth­er $162 mil­lion to the price tag.

The site in Sin­ga­pore is part of Sanofi’s mis­sion to spend $1.3 bil­lion over the next five years to cre­ate two sites for pan­dem­ic pre­pared­ness. The oth­er site will be in its na­tive France. The two will be able to pro­duce be­tween three and four vac­cines at once, while cur­rent man­u­fac­tur­ing sites on­ly al­low for the pro­duc­tion of a sin­gle vac­cine.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER